Yaerim Kim, Kyungho Ha, Jeonghwan Lee, Eunjin Bae, Jin Hyuk Paek, Woo Yeong Park, Kyubok Jin, Seungyeup Han, Dong Ki Kim, Chun Soo Lim, Jung Pyo Lee
{"title":"Effects of dietary fatty acid on all-cause mortality according to the kidney function based on the nationwide population study.","authors":"Yaerim Kim, Kyungho Ha, Jeonghwan Lee, Eunjin Bae, Jin Hyuk Paek, Woo Yeong Park, Kyubok Jin, Seungyeup Han, Dong Ki Kim, Chun Soo Lim, Jung Pyo Lee","doi":"10.23876/j.krcp.24.121","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although the relationship between fatty acids (FAs) and the risk of all-cause mortality has been long discussed, there is little evidence about the impact of each FA component on all-cause mortality by kidney function status.</p><p><strong>Methods: </strong>We used data from the U.S. National Health and Nutrition Examination Survey 1999-2016. The intake of FAs was estimated as a percentage of total energy using a 1-day 24-hour dietary recall and divided by quartiles; the first quartile was regarded as a reference. We used a multivariate Cox proportional hazard model to identify the impact of FAs on all-cause mortality.</p><p><strong>Results: </strong>Among 44,332 participants, during 129.0 ± 62.4 months of follow-up, there were 1,623 (6.2%), 3,109 (22.3%), and 2,202 deaths (53.1%) in the estimated glomerular filtration rate (eGFR) ≥90, 60-90, and <60 mL/min/1.73 m2 groups, respectively. Higher intake of SFAs significantly increased the risk of all-cause mortality in participants with eGFR 60-90 mL/min/1.73 m2 (adjusted hazard ratio, 1.20 in the 4th quartile). Likewise, higher intake of most PUFAs (octadecadienoic acid, octadecatrienoic acid, omega-6, and omega-3) significantly decreased the risk of all-cause mortality in participants with eGFR 60-90 mL/min/1.73 m2 . These effects of both SFAs and PUFAs were attenuated in participants with eGFR ≥90 and <60 mL/min/1.73 m2 .</p><p><strong>Conclusion: </strong>The impact of dietary FAs on all-cause mortality was prominent in participants with eGFR 60-90 mL/min/1.73 m2 . More specified and targeted counseling for restricting SFAs and encouraging PUFAs needs to be considered, especially for participants with marginally decreased kidney function.</p>","PeriodicalId":17716,"journal":{"name":"Kidney Research and Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Research and Clinical Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.23876/j.krcp.24.121","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Although the relationship between fatty acids (FAs) and the risk of all-cause mortality has been long discussed, there is little evidence about the impact of each FA component on all-cause mortality by kidney function status.
Methods: We used data from the U.S. National Health and Nutrition Examination Survey 1999-2016. The intake of FAs was estimated as a percentage of total energy using a 1-day 24-hour dietary recall and divided by quartiles; the first quartile was regarded as a reference. We used a multivariate Cox proportional hazard model to identify the impact of FAs on all-cause mortality.
Results: Among 44,332 participants, during 129.0 ± 62.4 months of follow-up, there were 1,623 (6.2%), 3,109 (22.3%), and 2,202 deaths (53.1%) in the estimated glomerular filtration rate (eGFR) ≥90, 60-90, and <60 mL/min/1.73 m2 groups, respectively. Higher intake of SFAs significantly increased the risk of all-cause mortality in participants with eGFR 60-90 mL/min/1.73 m2 (adjusted hazard ratio, 1.20 in the 4th quartile). Likewise, higher intake of most PUFAs (octadecadienoic acid, octadecatrienoic acid, omega-6, and omega-3) significantly decreased the risk of all-cause mortality in participants with eGFR 60-90 mL/min/1.73 m2 . These effects of both SFAs and PUFAs were attenuated in participants with eGFR ≥90 and <60 mL/min/1.73 m2 .
Conclusion: The impact of dietary FAs on all-cause mortality was prominent in participants with eGFR 60-90 mL/min/1.73 m2 . More specified and targeted counseling for restricting SFAs and encouraging PUFAs needs to be considered, especially for participants with marginally decreased kidney function.
期刊介绍:
Kidney Research and Clinical Practice (formerly The Korean Journal of Nephrology; ISSN 1975-9460, launched in 1982), the official journal of the Korean Society of Nephrology, is an international, peer-reviewed journal published in English. Its ISO abbreviation is Kidney Res Clin Pract. To provide an efficient venue for dissemination of knowledge and discussion of topics related to basic renal science and clinical practice, the journal offers open access (free submission and free access) and considers articles on all aspects of clinical nephrology and hypertension as well as related molecular genetics, anatomy, pathology, physiology, pharmacology, and immunology. In particular, the journal focuses on translational renal research that helps bridging laboratory discovery with the diagnosis and treatment of human kidney disease. Topics covered include basic science with possible clinical applicability and papers on the pathophysiological basis of disease processes of the kidney. Original researches from areas of intervention nephrology or dialysis access are also welcomed. Major article types considered for publication include original research and reviews on current topics of interest. Accepted manuscripts are granted free online open-access immediately after publication, which permits its users to read, download, copy, distribute, print, search, or link to the full texts of its articles to facilitate access to a broad readership. Circulation number of print copies is 1,600.